Micah Mackison Founder of Vico Therapeutics Backed byPolaris PartnersBryce YoungrenSteve Arnold LinkedIn SourcesVico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline — 2024-01 Browse all founders · Browse investors
